Last Updated: June 25, 2026

TECHNETIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Technetium, and when can generic versions of Technetium launch?

Technetium is a drug marketed by Ge Healthcare, Jubilant Draximage, Cardinal Health 414, Curium, Sun Pharm Inds Inc, Mallinckrodt, Jubilant, and Medi-radiopharma. and is included in seventeen NDAs.

The generic ingredient in TECHNETIUM is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TECHNETIUM?
  • What are the global sales for TECHNETIUM?
  • What is Average Wholesale Price for TECHNETIUM?
Summary for TECHNETIUM
US Patents:0
Applicants:8
NDAs:17
DailyMed Link:TECHNETIUM at DailyMed

US Patents and Regulatory Information for TECHNETIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT technetium tc-99m etidronate kit INJECTABLE;INJECTION 017562-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Inds Inc TECHNETIUM TC99M MERTIATIDE KIT technetium tc-99m mertiatide kit INJECTABLE;INJECTION 208994-001 Jul 12, 2019 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Jubilant Draximage TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078806-001 Apr 29, 2009 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ge Healthcare TECHNETIUM TC 99M MPI MDP technetium tc-99m medronate kit INJECTABLE;INJECTION 018141-002 Jun 12, 1989 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.